The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.

MLA

Cetin Gedik, Kader, et al. “The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.” Arthritis & Rheumatology, vol. 74, no. 5, May 2022, pp. 735–51. EBSCOhost, https://doi.org/10.1002/art.42087.

APA

Cetin Gedik, K., Lamot, L., Romano, M., Demirkaya, E., Piskin, D., Torreggiani, S., Adang, L. A., Armangue, T., Barchus, K., Cordova, D. R., Crow, Y. J., Dale, R. C., Durrant, K. L., Eleftheriou, D., Fazzi, E. M., Gattorno, M., Gavazzi, F., Hanson, E. P., Lee, K. M. A., & Montealegre Sanchez, G. A. (2022). The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS. Arthritis & Rheumatology, 74(5), 735–751. https://doi.org/10.1002/art.42087

Chicago

Cetin Gedik, Kader, Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani, Laura A. Adang, et al. 2022. “The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.” Arthritis & Rheumatology 74 (5): 735–51. doi:10.1002/art.42087.